Patients with immune thrombocytopenia (ITP) who received a first-in-class investigational drug in addition to standard therapy went longer without a bleeding episode that needed urgent treatment or ...
Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today ...
A groundbreaking gene therapy, BE-CAR7, has shown remarkable success in reversing an aggressive form of leukemia. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results